Trials / Recruiting
RecruitingNCT07149207
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Indocyanine Green (ICG) | Dose: 5 mg/kg IV injection prior to surgery |
Timeline
- Start date
- 2026-06-15
- Primary completion
- 2028-04-07
- Completion
- 2029-04-07
- First posted
- 2025-08-29
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07149207. Inclusion in this directory is not an endorsement.